Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21750)	6/3/1998 8:40:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< If the FDA ultimately agrees, Seragen Inc.'s Ontak could become the nation's first immunotoxin, a unique type of cancer fighter. >> So.......... A possible breakthru in the war against cancer, and LGND goes down! I'd hate to see the price of LGND, if they developed a cure for cancer and diabetes, at the same time! We'd be down to $5! Henry, or others, there is an article in S&P Personal Wealth, about LGND. Does anyone have access and some notes about the article? Or, has it been posted here, and I've missed it? Regards, Bob